Faculty

Izidore Lossos, M.D.

Associate Professor of Medicine and Director Lymphoma Program

305-243-6787 (office)
305-243-4785 (fax)
Sylvester Comprehensive Cancer Center, 1475 N.W. 12th Avenue, D8-4, Miami, Florida 33136
ilossos@med.miami.edu

 

Medicine/Hematology

Quick Jump



Curriculum Vitae

  • 1987 M.D. Hadassah Medical School, Hebrew University, Jerusalem, Israel
  • 1998-2001 Post Doctoral Fellowship Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
  • 1993-1996 Instructor Internal Medicine, Hebrew University, Jerusalem, Israel
  • 1996-2000 Assistant Professor Hematology and Internal Medicine, Hebrew University, Jerusalem, Israel
  • 2002-present Associate Professor Clinical Medicine, University of Miami, FL

Research Interests

The major interest of my laboratory is the molecular basis of human lymphoma. Our studies focus on alterations in gene expression, molecular prognostic factors, alterations in expression of oncogenes, abnormal signal transduction in lymphoma, interaction of lymphoma with the tumor microenvironment and the immunology of lymphoma. To address these issues we use ordinary molecular techniques, as well as gene expression profiling and real time PCR.

Current ongoing projects in the laboratory include:

  • Dissecting the function of HGAL- a gene that we recently cloned that has an important prognostic role in diffuse large cell lymphoma.
  • Distinct IL-4 Intracellular Signaling in Germinal Center B-cell like and Activated B-cell like Diffuse Large B-cell Lymphoma: Novel Opportunities for Therapeutic Interventions
  • Effects of IL-4 on Proliferation, Chemosensitivity-and Rituximab sensitivity of Germinal Center B-cell like (GCB) and Activated B-cell like (ABC) Diffuse Large B-cell Lymphoma
  • Studies of molecular markers for prediction of survival of lymphoma patients

Additional projects are planned to study the role of LMO2 in germinal centers and lymphoma.

Selected Publications

Natkunam Y, Hsi ED, Aoun P, Zhao S, Elson P, Pohlman B, Naushad H, Bast M, Levy R, Lossos IS. Expression of the Human Germinal Center Associated Lymphoma (HGAL) protein identifies a subset of classical Hodgkin Lymphoma of Germinal Center derivation and improved survival. Blood. 2007; 109:298-305.

Chen J, Byrne Jr GE, Lossos IS. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues. Diagn Mol Pathol. 2007, 16:61-72.

Lu X, Chen J, Tedjo Sasmono R, Hsi ED, Sarosiek KA, Tiganis T, Lossos IS. TCPTP, distinctively expressed in ABC-Like Diffuse Large B-Cell Lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol. 2007, 27:2166-2179.

Lu X, Chen J, Malumbres R, Cubedo Gil E, Helfman DM, Lossos IS. HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. Blood. 2007, 110:4268-4277.

Lu X, Nechushtan H, Ding F, Rosado MF, Singal R, Alizadeh AA, Lossos IS. Distinct IL-4 induced gene expression, proliferation and intracellular signaling in germinal center B-cell like and activated B-cell like diffuse large cell lymphomas. Blood. 2005; 105: 2924-2932.

Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R. Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes. NEJM. 2004; 350: 1828-1837.

Lossos IS, Akasaka T, Martinez-Climent JA, Siebert R, Levy R. The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene. Leukemia. 2003; 17:1390-1397.

Lossos IS, Czerwinski DK, Wechser MA, Levy R. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia. 2003;17:789-95.

Lossos IS, Alizadeh AA, Rajapaksa R, Tibshirani R, Levy R. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood. 2003; 101:433-440.

Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG, Garcia-Conde J, Dyer MJS, Levy R, Pinkel D, Lossos IS. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood. 2003;101:3109-3117.

Lossos IS, Alizadeh AA,, Diehn M, Warnke R, Thorstenson Y, Oefner PJ, Brown PO, Botstein D, Levy R. Transformation of Follicular Lymphoma to Diffuse Large Cell Lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A. 2002; 99: 8886-8891.

Lossos IS, Warnke R, Levy R. BCL-6 mRNA expression in higher-grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5’ regulatory region of the BCL-6 gene. Leukemia. 2002; 16:1857-1862.

Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R. The expression of single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood. 2001; 98:945-951.

Lossos IS, Okada CY, Tibshirani R, Warnke R, Vose JM, Greiner TC, Levy R. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 2000; 95:1797-1803.

Lossos IS, Alizadeh AA, Eisen MB, Chan WC, Brown PO, Botstein D, Staudt LM, Levy R. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A. 2000;97:10209-10213.